Now Available: Crohn's Disease - Pipeline Assessment and Market Forecasts to 2017

Jan. 16, 2011 - PRLog -- GlobalData, the industry analysis specialist's new report, "Crohn's Disease -Pipeline Assessment and Market Forecasts to 2017" is an essential source of information and analysis on the global Crohn's disease therapeutics market. The report identifies the key trends shaping and driving the global Crohn's disease therapeutics market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Crohn's disease therapeutics sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

GlobalData has estimated the global Crohn's disease therapeutics market to be valued at $2.8 billion in 2009. It is expected to grow to $4.7 billion with a Compound Annual Growth Rate (CAGR) of 6.6% by 2017. This growth is primarily attributed to the increased competition among the existing products and also the strong pipeline with more emerging therapies. The growth will be further supported by the increased uptake of biologics. The growth is attributed to the launches of the biologics which include Humira (Adalimumab), Cimzia (certolizumab pegol) and Tysabri (natalizumab).

Scope

The report provides information on the key drivers and challenges of the global crohn's disease therapeutics market. Its scope includes:

* Annualized global Crohn's disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2017.
* Key geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
* Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes TNF-alpha inhibitors, stem cell therapy, CCR9 antagonist ,integrin alpha (4) antagonist ,hormone therapy, COX-1 Inhibitor, JAK inhibitors, cytokine production inhibitors, opioid antagonists, NPY Y4 selective agonists, peptidase inhibitors, monoclonal antibodies, selective ROCK I/II inhibitors, permeability inhibitors, TL-1 inhibitors, angiotensin converting enzyme 2 inhibitors, GLP-2 agonist.
* Analysis of the current and future market competition in the global Crohn's disease market. Key market players covered are Ocera Therapeutics, ChemoCentryx, Osiris, Giaconda Limited, Takeda Pharmaceuticals, Centocor, PanGenetics B.V, Enzo Biochem, Inc., Txcell SA, Pfizer Inc., Celgene Corporation, 7TM Pharma A/S, Teva Pharmaceutical Industries Limited and Amgen.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Crohn's disease


Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Crohn's disease therapeutics market.
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Crohn's disease therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolio and create effective   counter-strategies to gain competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Crohn's disease therapeutics market landscape? - Identify, understand and capitalize.



For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/109274_crohns_disease_pipeline...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.